CysLT1 antagonists alter survival, long-term proliferation, metabolism, and the secretion of pro-inflammatory and pro-angiogenic factors in in vitro UM cell line models and can promote anti-cancer activity in in vivo zebrafish xenograft models of UM. Here, CYSLTR1 is linked to cancer.